TARGEGEN
TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation. The company offers its products for the treatment of human diseases, such as heart attack, cancer, and eye diseases; vascular leakage, edema, and the unwanted growth of new blood vessels; pleural effusions, arthritis, pulmonary edema, transplant ischemia, ARDS, brain inflammatio... n, hypovolemia (acute blood loss) CNS disorders, and other serious medical conditions. It serves macular degeneration, diabetic macular edema, and diabetic retinopathy markets. The company was founded in 2002 and is based in San Diego, California. It was acquired by [Sanofi Aventis](/organization/sanofi-aventis-2) in 2010.
TARGEGEN
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2002-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.targegen.com
Total Employee:
11+
Status:
Active
Contact:
(858)678-0760
Email Addresses:
[email protected]
Total Funding:
113.72 M USD
Similar Organizations
Ambit Biosciences
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series D - TargeGen
Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management investment in Series D - TargeGen
Chicago Growth Partners
Chicago Growth Partners investment in Series D - TargeGen
Innovis Investments
Innovis Investments investment in Series D - TargeGen
Forward Ventures
Forward Ventures investment in Series D - TargeGen
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Series D - TargeGen
VantagePoint Capital Partners
VantagePoint Capital Partners investment in Series D - TargeGen
BB Biotech Ventures
BB Biotech Ventures investment in Series D - TargeGen
Pappas Ventures
Pappas Ventures investment in Series D - TargeGen
Enterprise Partners
Enterprise Partners investment in Series D - TargeGen
Official Site Inspections
http://www.targegen.com
- Host name: ec2-52-20-84-62.compute-1.amazonaws.com
- IP address: 52.20.84.62
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "TargeGen"
TargeGen - Crunchbase Company Profile & Funding
TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular …See details»
TargeGen, Inc. - LinkedIn
Specialties TargeGen, Inc. is a privately held biopharmaceutical company based in San Diego, and CA. TargeGen primarily develops small molecule kinase inhibitors for applications in …See details»
TargeGen 2025 Company Profile: Valuation, Investors ... - PitchBook
TargeGen was founded in 2002. Where is TargeGen headquartered? TargeGen is headquartered in San Diego, CA. What industry is TargeGen in? TargeGen’s primary industry is …See details»
Targegen — CTI Life Sciences
Headquartered in San Diego, Targegen was a private company founded in 2001.The mission of the company was to use its expertise in vascular biology and knowledge regarding the src …See details»
TargeGen - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Targegen, Inc. Company Profile | San Diego, CA | Competitors ...
Company Description: TargeGen is developing small molecule therapeutics to treat hematological malignancies, or for the layperson, cancer and other disorders of the blood, bone marrow, and …See details»
TargeGen - Raised $73.7M Funding from 10 investors - Tracxn
Mar 21, 2025 List of TargeGen's institutional investors. Forward Ventures, located in San Diego (United States), made their first investment in TargeGen on Jan 15, 2004 in its Series B …See details»
TargeGen, Inc. Overview | SignalHire Company Profile
Organization Website: targegen.com : TargeGen, Inc. industries Pharma: TargeGen, Inc. Employees Size 10-50 employees: Specialties: TargeGen, Inc. is a privately held …See details»
TargeGen - Tech Company Profile - Gaebler.com Venture Capital …
TargeGen. TargeGen, based in San Diego, has financial backing from Chicago Growth Partners, VantagePoint Capital Partners and Enterprise Partners Venture Capital. Company Overview. …See details»
TargeGen - Products, Competitors, Financials, Employees, …
Headquarters Location. 9380 Judicial Drive . San Diego, California, 92121, United States. 858-678-0760See details»
TargeGen - Overview, News & Similar companies | ZoomInfo.com
Who is TargeGen. TargeGen, Inc. is a privately held vascular biology-focused biopharmaceutical company based in San Diego, CA. TargeGen primarily develops small mol ecule kinase …See details»
Targegen Inc. Information | CareersInPharmaceutical.com
Targegen Inc., is a privately held biopharmaceutical company based in San Diego and combines a focus on vascular biology with expertise in small molecule medicinal chemistry. TargeGen …See details»
Sanofi-aventis to acquire TargeGen Inc. | Fierce Biotech
Jun 30, 2010 Sanofi-aventis to acquire TargeGen Inc., a US biopharmaceutical company - Development of oral potent oncology medicines for the treatment of hematological …See details»
TargeGen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore TargeGen, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 2 news, and 29 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
TargeGen - Contacts, Employees, Board Members, Advisors
TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target.See details»
TargeGen Inc. - San Diego, USA - bionity.com
Jul 2, 2010 TargeGen, Inc., formed in 2001, is a privately held biopharmaceutical company based in San Diego, CA. The company develops small molecule kinase inhibitors for the …See details»
TargeGen - Pappas Capital
May 14, 2009 Sanofi is currently developing TargeGen’s lead compound for the treatment of myelofibrosis and polycythemia vera, debilitating blood disorders for which there is a very …See details»
Sanofi buys TargeGen to boost cancer treatments | Reuters
PARIS, June 30 (Reuters) - Sanofi-Aventis is to buy U.S. biotech TargeGen Inc., which is developing treatments against blood diseases, for as much as $560 million as part of the …See details»
Target Org Chart + Executive Team - The Official Board
The organizational chart of Target displays its 146 main executives including Brian Cornell, Jim Lee, Michael Fiddelke and Michael O'NeilSee details»
How a Columbia Student Activist Landed in Federal Detention
Mar 16, 2025 “When you lead an organization, you are accountable for your organization’s actions,” Mr. Davidai said. “When you lead an organization that openly and proudly supports a …See details»